Notice of Lodging of Proposed Consent Decree Under the Clean Air Act
Published Date: 1/30/2026
Notice
Summary
The government is updating a deal with Birla Carbon U.S.A. (formerly Columbian Chemical Company) to clean up air pollution at their factories in Louisiana and Kansas. They’re changing deadlines for installing pollution control gear and meeting limits on harmful emissions like sulfur dioxide and nitrogen oxides. People have 30 days to share their thoughts before the new rules take effect.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Deadlines to Install Pollution Controls Changed
The proposed amendment revises the Consent Decree deadlines for Birla Carbon U.S.A. (formerly Columbian Chemical Company) to install and begin continuously operating certain air pollution control equipment at its carbon black manufacturing facilities in North Bend, Louisiana, and Hickok, Kansas.
Emissions Limits Deadline Revisions
The proposed Consent Decree amendment revises the deadlines for Birla Carbon U.S.A. to achieve and continuously maintain specified limits on emissions of sulfur dioxide (SO2), nitrogen oxides (NOx), and particulate matter (PM) from its facilities.
30-Day Public Comment Opportunity
The Department of Justice opened a public comment period on the proposed Consent Decree amendment; comments must be submitted no later than thirty (30) days after the publication date of this notice (publication date: January 30, 2026).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-14135 — David Enright, M.D.; Decision and Order
Dr. David Enright from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately.
2026-14136 — Barlow St-Clair Lynch, M.D.; Decision and Order
Dr. Barlow St-Clair Lynch from Maine lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA moved forward and officially revoked his registration. This means he can’t prescribe or manage controlled drugs anymore, effective immediately, impacting his medical practice and any related income.
2026-14137 — Shane Lydon, M.D.; Decision and Order
Dr. Shane Lydon's license to handle controlled substances in Maine has been revoked because he lost his state authority and didn’t ask for a hearing. This means he can no longer prescribe or manage these drugs, effective immediately. Anyone relying on his registration should update their records and note this change to avoid legal trouble.
Previous / Next Documents
Previous: 2026-01812 — Fresh Winter Strawberries From Mexico; Revised Schedule for the Subject Investigation
The U.S. International Trade Commission is updating the timeline for its investigation into fresh winter strawberries from Mexico. This change follows a new deadline set by the Department of Commerce, pushing some key dates into early February 2026. Strawberry growers, importers, and buyers should watch for these updates as they could affect trade rules and costs soon.
Next: 2026-01814 — Agency Information Collection Activities; Comment Request on Annual Return/Report of Employee Benefit Plan
The IRS wants your thoughts on the yearly report that employee benefit plans must file. If you manage or work with these plans, this is your chance to help make the process easier and clearer. Send your comments by March 31, 2026, so the IRS can improve the forms and reduce hassle without adding extra costs or time burdens.